Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2018-07-26 2018-07-26
Drug Identification Number 02241639 02241639
Brand name CEFUROXIME FOR INJECTION, USP CEFUROXIME FOR INJECTION, USP
Common or Proper name Cefuroxime Cefuroxime
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients CEFUROXIME CEFUROXIME
Strength(s) 1.5G 1.5G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1.5g 1.5g
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-06-01 2018-06-01
Estimated end date 2018-07-25 2018-07-25
Actual end date 2018-07-25 2018-07-25
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments